Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Laux

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Pharmazie in Unserer Zeit|December 17, 2002
[Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics]Gerd Laux, Wilfried Günther
Psychiatrische Praxis|December 1, 2004
[Medical controlling seen by the head of hospital]Gerd Laux, Ruth Höfter
Pharmacopsychiatry|July 19, 2017
Driving Under the Influence of Antidepressants: A Systematic Review and Update of the Evidence of Experimental and Controlled Clinical StudiesAlexander Brunnauer, Gerd Laux
Pharmacopsychiatry|September 13, 2017
Editorial to Driving Ability and Psychotropic DrugsGerd Laux, Michael Bauer
Psychiatrische Praxis|December 1, 2004
[What are the differences between a year later remitted and non-remitted depressive patients? Results of a retrospective long-term study at the Bezirksklinikum Gabersee]Sissi Artmann, Gerd Laux
Psychiatrische Praxis|September 18, 2003
[Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine]Mirijam Fric, Gerd Laux
Psychiatrische Praxis|September 18, 2003
[Antidepressants and Driving Ability]Alexander Brunnauer, Gerd Laux
Experimental Neurobiology|November 24, 2011
MAO-inhibitors in Parkinson's DiseasePeter Riederer, Gerd Laux
Psychiatrische Praxis|September 26, 2003
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]Mirijam Fric, Gerd Laux
Journal of Neural Transmission (Vienna, Austria : 1996)|June 12, 2012
The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review : 70th Birthday Prof. RiedererAlexander Brunnauer, Gerd Laux
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Pharmazie in Unserer Zeit|December 17, 2002
[Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics]Gerd Laux, Wilfried Günther
Psychiatrische Praxis|December 1, 2004
[Medical controlling seen by the head of hospital]Gerd Laux, Ruth Höfter
Pharmacopsychiatry|July 19, 2017
Driving Under the Influence of Antidepressants: A Systematic Review and Update of the Evidence of Experimental and Controlled Clinical StudiesAlexander Brunnauer, Gerd Laux
Pharmacopsychiatry|September 13, 2017
Editorial to Driving Ability and Psychotropic DrugsGerd Laux, Michael Bauer
Psychiatrische Praxis|December 1, 2004
[What are the differences between a year later remitted and non-remitted depressive patients? Results of a retrospective long-term study at the Bezirksklinikum Gabersee]Sissi Artmann, Gerd Laux
Psychiatrische Praxis|September 18, 2003
[Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine]Mirijam Fric, Gerd Laux
Psychiatrische Praxis|September 18, 2003
[Antidepressants and Driving Ability]Alexander Brunnauer, Gerd Laux
Experimental Neurobiology|November 24, 2011
MAO-inhibitors in Parkinson's DiseasePeter Riederer, Gerd Laux
Psychiatrische Praxis|September 26, 2003
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]Mirijam Fric, Gerd Laux
Journal of Neural Transmission (Vienna, Austria : 1996)|June 12, 2012
The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review : 70th Birthday Prof. RiedererAlexander Brunnauer, Gerd Laux
Pageof 10